IMGO
Income statement / Annual
Last year (2021), Imago BioSciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, Imago BioSciences, Inc.'s net income was -$42.31 M.
See Imago BioSciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
| Research and Development Expenses |
$32.26 M
|
$14.90 M
|
$8.24 M
|
| General & Administrative Expenses |
$10.26 M
|
$3.18 M
|
$2.42 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.26 M
|
$3.18 M
|
$2.42 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$42.52 M
|
$18.07 M
|
$10.66 M
|
| Cost And Expenses |
$42.52 M
|
$18.07 M
|
$10.66 M
|
| Interest Income |
$314.00 K
|
$48.00 K
|
$38.00 K
|
| Interest Expense |
$314.00 K
|
$48.00 K
|
$38.00 K
|
| Depreciation & Amortization |
$6.00 K
|
$1.00 K
|
-$208.00 K
|
| EBITDA |
-$42.52 M |
-$17.78 M |
-$10.86 M |
| EBITDA Ratio |
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$215.00 K
|
$242.00 K
|
-$246.00 K
|
| Income Before Tax |
-$42.31 M
|
-$17.83 M
|
-$10.90 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
| Income Tax Expense |
$2.00 K
|
$3.00 K
|
$0.00
|
| Net Income |
-$42.31 M
|
-$17.83 M
|
-$10.90 M
|
| Net Income Ratio |
0
|
0
|
0
|
| EPS |
-1.26 |
-0.79 |
-0.49 |
| EPS Diluted |
-1.26 |
-0.79 |
-0.49 |
| Weighted Average Shares Out |
$33.58 M
|
$22.47 M
|
$22.47 M
|
| Weighted Average Shares Out Diluted |
$33.58 M
|
$22.47 M
|
$22.47 M
|
| Link |
|
|
|
